A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It found that semaglutide, the substance in Ozempic and the weight loss drug Wegovy, could in fact help curb alcohol cravings
GLP-1 medications are not recommended for patients with severe gastroparesis
While they both fight oxidative stress, they operate in different areas of the cell and use different methods to keep you healthy
This is an attractive option for all those who wish to improve localized fat accumulation without running the risks of surgery
Its main role in research is linked to fat redistribution and changes in body composition
The test examines 14 peptide-hormone pathways and 150+ genetic insights, including variants in the GLP1R gene (rs6923761), which directly affects how your body responds to semaglutide